(Q37355092)

19 August 2017

Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines (English)

1 reference

19 August 2017

1 reference

A A Liem

1

1 reference

19 August 2017

M V C L Appleyard

2

1 reference

19 August 2017

M A O'Neill

3

1 reference

19 August 2017

T R Hupp

4

1 reference

19 August 2017

M P Chamberlain

5

1 reference

19 August 2017

A M Thompson

6

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

British Journal of Cancer

19 August 2017

1 reference

19 August 2017

88

1 reference

19 August 2017

8

1 reference

19 August 2017

1281-1284

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600898

19 August 2017

0 references

cites work

The role of signal transduction in cancer treatment and drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

New cytotoxic agents and schedules for advanced breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

6 September 2017

Surfing the p53 network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Strategies for manipulating the p53 pathway in the treatment of human cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Signal transduction by the JNK group of MAP kinases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Signaling networks: the origins of cellular multitasking

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Cellular mechanisms of multidrug resistance of tumor cells.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Mitogen-activated protein kinase cascade in breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Current options in treatment of anthracycline-resistant breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Hyperexpression of mitogen-activated protein kinase in human breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Protein modules and signalling networks

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Vinorelbine (Navelbine) in the treatment of breast cancer: the European experience.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Regulation of p53 expression by the RAS-MAP kinase pathway

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747573

A polyphenolic fraction from grape seeds causes irreversible growth inhibition of breast carcinoma MDA-MB468 cells by inhibiting mitogen-activated protein kinases activation and inducing G1 arrest and differentiation

2 September 2018

1 reference

12 December 2020

Cell signaling: an overview

1 reference

12 December 2020

MAP kinase pathway signalling is essential for extracellular matrix determined mammary epithelial cell survival

1 reference

12 December 2020

25th European Society of Medical Oncology (ESMO) Congress. Hamburg, Germany, 13-17 October 2000. Abstracts

1 reference

12 December 2020

Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice

1 reference

12 December 2020

P53 and breast cancer

1 reference

12 December 2020

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600898

1 reference

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.BJC.6600898

1 reference

Dimensions Publication ID

19 August 2017

0 references

1 reference

19 August 2017

PubMed publication ID

12698197

1 reference